Citigroup’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Sell
34,000
-188,000
-85% -$14.8M ﹤0.01% 2547
2025
Q4
$18.2M Hold
222,000
0.01% 1167
2025
Q3
$16.7M Buy
222,000
+68,000
+44% +$5.07M 0.01% 1179
2025
Q2
$11.4M Sell
154,000
-640,000
-81% -$44.6M 0.01% 1293
2025
Q1
$64.1M Buy
794,000
+722,000
+1,003% +$62.1M 0.03% 481
2024
Q4
$5.63M Hold
72,000
﹤0.01% 1838
2024
Q3
$6.76M Hold
72,000
﹤0.01% 1603
2024
Q2
$5.61M Hold
72,000
﹤0.01% 1553
2024
Q1
$6.55M Buy
+72,000
New +$5.99M ﹤0.01% 1529

Other funds holding GEHC

Citigroup's GEHC Position: Q1 2026 in Review

Citigroup increased its GE HealthCare (GEHC) stake by 3.1% in Q1 2026, buying an estimated $1.53M and bringing the position to 648,314 shares worth $46.1M. The position accounts for 0.02% of the portfolio, ranked #673.

Citigroup first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $81.7M in Q3 2024. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Citigroup held 648,314 shares of GE HealthCare worth $46.1M as of Q1 2026.
  • Citigroup bought 19,391 GE HealthCare shares in Q1 2026, an estimated $1.53M.
  • GE HealthCare made up 0.02% of Citigroup's portfolio in Q1 2026, its #673 holding.
  • Citigroup first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Citigroup's GE HealthCare position peaked at $81.7M in Q3 2024.
  • 1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.